Metformin in perimenopause: where it fits and where it doesn't

Why blood sugar can drift in midlife

Many women notice weight settling around the middle in their 40s and early 50s. The Office on Women's Health notes that women gain about 5 pounds on average after menopause, and that falling estrogen, slower metabolism, less activity and age-related muscle loss all play a part. That weight gain, in turn, raises the risk of high blood pressure, high cholesterol and diabetes.

Insulin resistance, where the body responds less well to insulin, can build quietly alongside these changes. NIDDK lists a large waist, overweight, age, family history and physical inactivity among the risk factors. A rising A1c or fasting glucose on routine labs is often the first clue.

Two histories that change the picture

A pregnancy many years ago can still matter now. The CDC reports that about half of women who had gestational diabetes go on to develop type 2 diabetes. Polycystic ovary syndrome (PCOS) is also listed by NIDDK and the CDC as a risk factor for prediabetes and type 2 diabetes, and its metabolic features do not simply disappear when periods become irregular in perimenopause.

These histories are relevant to metformin specifically. In the Diabetes Prevention Program, metformin was most effective at delaying type 2 diabetes in women with a history of gestational diabetes. NICHD notes that metformin is used off-label in PCOS to improve insulin response and some symptoms, though it is not FDA-approved for PCOS.

What metformin can and cannot do here

Metformin lowers the glucose your liver releases and improves your response to insulin. In a woman with prediabetes, it may slow the path toward type 2 diabetes. It may lead to a small amount of weight loss, but the effect is modest and inconsistent.

It does not replace estrogen, does not ease hot flashes or night sweats, and does not directly change your sex hormone levels in a way that treats menopause symptoms. If your main concerns are vasomotor symptoms, sleep disruption or vaginal dryness, hormone therapy or other targeted treatments are the place to start.

Metformin, hormone therapy and GLP-1 medicines

These treatments answer different questions, so they are not really competitors.

Many women use more than one. Metformin and hormone therapy have no well-known direct interaction, but your clinician should still review the whole medicine list.

• Hormone therapy addresses menopause symptoms and is chosen after an individual discussion of benefits and risks such as blood clots, stroke and breast cancer
• Metformin targets blood sugar and insulin resistance, and suits women with prediabetes or strong diabetes risk factors who want an inexpensive oral option
• GLP-1 medicines produce substantially more weight loss and may be considered when weight itself is the main health issue and criteria are met
• Lifestyle change, including strength training to protect muscle, underpins all three and did more than metformin in the DPP

Labs worth checking first

A decision about metformin should rest on numbers, not just on how your jeans fit. Common starting tests include:

• A1c and fasting glucose to look for prediabetes
• A lipid panel, since blood fats often rise with insulin resistance
• Kidney function (eGFR), which determines whether metformin is safe and at what dose
• Vitamin B12, which can fall with long-term metformin use
• Sometimes fasting insulin, though NIDDK notes insulin resistance tests are mainly used in research rather than routine care, so results need careful interpretation

A practical way to think about it

Picture three women in their late 40s. One has troublesome night sweats and normal labs; her conversation is about hormone therapy, not metformin. Another has an A1c of 6.1 percent, a history of gestational diabetes and a strong family history of diabetes; metformin, alongside lifestyle change, is a reasonable option to discuss. A third has a BMI in the obesity range with rising blood pressure; a GLP-1 medicine may be part of her discussion. Your own situation may blend these, and that is exactly what a clinician visit is for.

Side effects and safety

Stomach upset, including diarrhea, nausea and gas, is the most common problem and tends to ease with time, a gradual dose increase and an extended-release tablet. Metformin carries a boxed warning for lactic acidosis, a rare but serious reaction that is more likely with kidney problems, heavy drinking or severe illness. It is not usually used during pregnancy for this purpose, so tell your clinician if pregnancy is possible.

Getting started with HealifyMD

With HealifyMD, a licensed clinician reviews your symptoms, history, labs and goals, and can address hormone therapy and metabolic health in the same plan. Metformin costs $149 for 3 months ($50/month) and hormone therapy for women is $349 the first month (including baseline labs), then $99/month; prices are confirmed at your eligibility review and other labs are priced separately.